Matches in Nanopublications for { ?s ?p "[The rationale of ?1-antitrypsin (AAT) augmentation therapy to treat progressive emphysema in AAT-deficient patients is based on inhibition of neutrophil elastase; however, the benefit of this treatment remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[The rationale of ?1-antitrypsin (AAT) augmentation therapy to treat progressive emphysema in AAT-deficient patients is based on inhibition of neutrophil elastase; however, the benefit of this treatment remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The rationale of ?1-antitrypsin (AAT) augmentation therapy to treat progressive emphysema in AAT-deficient patients is based on inhibition of neutrophil elastase; however, the benefit of this treatment remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1105281.RAVbNmMXGmcgoMRwN5GB-Vb8Fl_YLGxxTdWiYZEN2Mt0g130_assertion description "[The rationale of ?1-antitrypsin (AAT) augmentation therapy to treat progressive emphysema in AAT-deficient patients is based on inhibition of neutrophil elastase; however, the benefit of this treatment remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1105281.RAVbNmMXGmcgoMRwN5GB-Vb8Fl_YLGxxTdWiYZEN2Mt0g130_provenance.
- NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_assertion description "[The rationale of ?1-antitrypsin (AAT) augmentation therapy to treat progressive emphysema in AAT-deficient patients is based on inhibition of neutrophil elastase; however, the benefit of this treatment remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_provenance.